These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24282370)
1. Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes. Karmacharya P; Aryal MR; Donato A World J Gastroenterol; 2013 Nov; 19(43):7813-5. PubMed ID: 24282370 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulation and delayed bowel resection in the management of mesenteric venous thrombosis. Kim HK; Chun JM; Huh S World J Gastroenterol; 2013 Aug; 19(30):5025-8. PubMed ID: 23946612 [TBL] [Abstract][Full Text] [Related]
3. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
5. Heterozygosity for factor V Leiden and G20210A prothrombin genotypes in a patient with mesenteric vein thrombosis. Al-Juburi A; Scott MA; Shah HR; Raufman JP Dig Dis Sci; 2002 Mar; 47(3):601-6. PubMed ID: 11911349 [No Abstract] [Full Text] [Related]
6. Inherited Thrombophilia in a Lebanese Family of Four Generations: A Case Report of Recurrent Miscarriage. Khalife S; Bissar-Tadmouri N Vasc Health Risk Manag; 2020; 16():53-56. PubMed ID: 32021228 [TBL] [Abstract][Full Text] [Related]
7. Portal, splenic and mesenteric vein thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation. Grouzi E; Politou M; Douramani P; Merkouri E; Gialeraki A; Brountzos H; Perros G; Travlou A Blood Coagul Fibrinolysis; 2009 Dec; 20(8):722-5. PubMed ID: 19734780 [TBL] [Abstract][Full Text] [Related]
8. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs. Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G; Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310 [TBL] [Abstract][Full Text] [Related]
9. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A. Federici EH; Al-Mondhiry H Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339 [TBL] [Abstract][Full Text] [Related]
10. [APC resistance due to factor V Leiden mutation presenting as acute hemorrhagic jejunal infarction--case report]. Garlipp B; Gerhardt U; Linke J; Arlt G Z Gastroenterol; 2008 Feb; 46(2):206-10. PubMed ID: 18253900 [TBL] [Abstract][Full Text] [Related]
11. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Marchiori A; Mosena L; Prins MH; Prandoni P Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440 [TBL] [Abstract][Full Text] [Related]
12. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522 [TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938 [TBL] [Abstract][Full Text] [Related]
14. Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis. Lamparello BM; Erickson CR; Kulthia A; Virparia V; Thet Z Vasc Health Risk Manag; 2014; 10():609-13. PubMed ID: 25395858 [TBL] [Abstract][Full Text] [Related]
15. Prothrombin gene G20210A mutation and elevated anticardiolipin antibodies in a patient with combined portal-mesenteric vein thrombosis. Friederich P; Putensen C; Stüber F Intensive Care Med; 2000 Oct; 26(10):1571-4. PubMed ID: 11126275 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis. Gessoni G; Valverde S Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Amitrano L; Brancaccio V; Guardascione MA; Margaglione M; Iannaccone L; Dandrea G; Ames PR; Marmo R; Mosca S; Balzano A Am J Gastroenterol; 2001 Jan; 96(1):146-9. PubMed ID: 11197244 [TBL] [Abstract][Full Text] [Related]
19. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation. Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M; Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523 [TBL] [Abstract][Full Text] [Related]
20. Sudden hearing loss followed by deep vein thrombosis and pulmonary embolism in a patient with factor V Leiden mutation. Lovato A; Tormene D; Staffieri C; Breda S; Staffieri A; Marioni G Int J Audiol; 2014 Sep; 53(9):625-8. PubMed ID: 24735015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]